Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-12-10
著者
-
Rabbani Hodjatallah
Monoclonal Antibody Research Center Avicenna Research Institute Acecr
-
Razavi Seyed
Clinic Of Hematology And Oncology Firozgar Hospital Faculty Of Medicine Iran University Of Medical S
-
HOJJAT-FARSANGI Mohammad
Department of Immunology, School of Public Health, Tehran University of Medical Sciences
-
JEDDI-TEHRANI Mahmood
Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR
-
SHARIFIAN Ramazan
Clinic of Hematology and Oncology, Vali-Asr Hospital, Faculty of Medicine, Tehran University of Medi
-
MELLSTEDT Hakan
Immune and Gene Therapy Lab, Cancer Center Karolinska, Karolinska Hospital
-
SHOKRI Fazel
Department of Immunology, School of Public Health, Tehran University of Medical Sciences
-
Sharifian Ramazan
Clinic Of Hematology And Oncology Vali-asr Hospital Faculty Of Medicine Tehran University Of Medical
-
Mellstedt Hakan
Immune And Gene Therapy Lab Cancer Center Karolinska Karolinska Hospital
-
Hojjat-farsangi Mohammad
Department Of Immunology School Of Public Health Tehran University Of Medical Sciences
-
Shokri Fazel
Department Of Immunology School Of Public Health Tehran University Of Medical Sciences
-
Jeddi-tehrani Mahmood
Monoclonal Antibody Research Center Avicenna Research Institute Acecr
関連論文
- Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia
- Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes